Roche Gains With Tecentriq IMpower131 NSCLC Data, But For How Long?

 
• By Sten Stovall
Lung cancer
Roche Released Positive IMpower131 Data In Initial Squamous Cell Lung Cancer • Source: Shutterstock

More from Clinical Trials

More from R&D